Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer
-
- EGAMI Takuya
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- OHUCHIDA Kenoki
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- MIYOSHI Kei
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- MIZUMOTO Kazuhiro
- Cancer Center, Kyushu University
-
- ONIMARU Manabu
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- TOMA Hiroki
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- SATO Norihiro
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- MATSUMOTO Kunio
- Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University
-
- TANAKA Masao
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
Search this Article
Author(s)
-
- EGAMI Takuya
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- OHUCHIDA Kenoki
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- MIYOSHI Kei
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- MIZUMOTO Kazuhiro
- Cancer Center, Kyushu University
-
- ONIMARU Manabu
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- TOMA Hiroki
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- SATO Norihiro
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
- MATSUMOTO Kunio
- Division of Tumor Dynamics and Regulation, Cancer Research Institute, Kanazawa University
-
- TANAKA Masao
- Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
Journal
-
- Cancer Sci
-
Cancer Sci 100(4), 722-729, 2009-04-10
References: 58
-
1
- The molecular genetics of pancreatic ductal carcinoma : a review
-
SOHN TA
Surg Oncol 9, 95-101, 2000
Cited by (1)
-
2
- New concepts of molecular biology on gastric carcinogenesis
-
KOUNTOURAS J
Hepato-Gastroenterology 52, 1305-1312, 2005
Cited by (1)
-
3
- Targeted therapies in solid tumors : monoclonal antibodies and small molecules
-
WEINER LM
Hum Antibodies 15, 103-111, 2006
Cited by (1)
-
4
- Molecular therapy in pancreatic adenocarcinoma
-
MACKENZIE MJ.
Lancet Oncol 5, 541-549, 2004
Cited by (1)
-
5
- Novel clinical strategies for the treatment of pancreatic carcinoma
-
GUNZBURG WH
Trends Mol Med 7, 30-37, 2001
Cited by (1)
-
6
- Pancreatic carcinoma
-
WARSHAW AL
N Engl J Med 326, 455-465, 1992
Cited by (1)
-
7
- Treatment and survival in 13 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands : an epidemiological study
-
BRAMHALL SR
Br J Surg 82, 111-115, 1995
Cited by (1)
-
8
- Pancreatic cancer biology and genetics
-
BARDEESY N
Nat Rev 2, 897-909, 2002
Cited by (1)
-
9
- Focus on pancreas cancer
-
JAFFEE EM
Cancer Cell 2, 25-28, 2002
Cited by (1)
-
10
- Matrix metalloproteinases and their role in pancreatic cancer. a review of preclinical studies and clinical trials
-
BLOOMSTON M
Ann Surg Oncol 9, 668-674, 2002
Cited by (1)
-
11
- Molecular biomarkers : their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer
-
JIMENO A
Mol Cancer Ther 5, 787-796, 2006
Cited by (1)
-
12
- Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival
-
OGURA Y
Cancer Gene Ther 13, 520-529, 2006
Cited by (1)
-
13
- Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice
-
MURAKAMI M
Int J Cancer 117, 160-165, 2005
Cited by (1)
-
14
- Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas : a phase I trial
-
MULVIHILL S
Gene Ther 8, 308-315, 2001
Cited by (1)
-
15
- Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
-
SANGRO B
J Clin Oncol 22, 1389-1397, 2004
Cited by (1)
-
17
- Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model
-
SHIEH GS
Cancer Res 66, 9957-9966, 2006
Cited by (1)
-
18
- The effect of adenovirus-IkappaBalpha transduction on the chemosensitivity of lung cancer cell line with resistance to cis-diamminedichloroplatinum (II) (cisplatin) and doxorubicin (adriamycin)
-
LEE CT
Lung Cancer 41, 199-206, 2003
Cited by (1)
-
19
- Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer
-
LEE J
Oncology 66, 32-37, 2004
Cited by (1)
-
20
- Irinotecan plus gemcitabine and 5-fluorouracil in advanced pancreatic cancer : a phase II study
-
ENDLICHER E
Oncology 72, 279-284, 2007
Cited by (1)
-
21
- A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer
-
MORIZANE C
Cancer Chemother Pharmacol 63, 313-319, 2009
Cited by (1)
-
22
- PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapy
-
RENI M
Am J Clin Oncol 31, 145-150, 2008
Cited by (1)
-
23
- A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma : a Southwest Oncology Group study
-
MACDONALD JS
Invest New Drugs 18, 269-273, 2000
Cited by (1)
-
24
- Coexpression of the c-met protooncogene and hepatocyte growth factor in human pancreatic cancer
-
EBERT M
Cancer Res 54, 5775-5778, 1994
Cited by (1)
-
26
- NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells
-
MAEHARA N
Br J Cancer 84, 864-873, 2001
Cited by (1)
-
27
- Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer
-
MAEHARA N
Clin Exp Metastasis 19, 417-426, 2002
Cited by (1)
-
28
- Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice
-
SAIMURA M
Cancer Gene Ther 9, 799-806, 2002
Cited by (1)
-
29
- Combination therapy of S-1 with selective cyclooxygenase-2 inhibitor for liver metastasis of colorectal carcinoma
-
TACHIMORI A
Anticancer Res 28, 629-638, 2008
Cited by (1)
-
30
- Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines : role of gefitinib-induced down-regulation of thymidylate synthase
-
OKABE T
Mol Cancer Ther 7, 599-606, 2008
Cited by (1)
-
31
- Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy
-
MAEMONDO M
Mol Ther 5, 177-185, 2002
Cited by (1)
-
32
- In vitro and in vivo transfer and expression of human surfactant SP-A- and SP-B-associated protein cDNAs mediated by replication-deficient, recombinant adenoviral vectors
-
KORST RJ
Hum Gene Ther 6, 277-287, 1995
Cited by (1)
-
33
- Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion
-
SATO N
Cancer 91, 496-504, 2001
Cited by (1)
-
34
- Quantitative determination of apoptotic death in cultured human pancreatic cancer cells by propidium iodide and digitonin
-
ZHANG L
Cancer Lett 142, 129-137, 1999
Cited by (1)
-
35
- Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer xenografts
-
ZHANG M
Mol Ther 8, 21-28, 2003
Cited by (1)
-
36
- Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2
-
QIAN J
Cancer Res 65, 5493-5497, 2005
Cited by (1)
-
37
- S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis
-
OHUCHIDA K
Clin Cancer Res 12, 5417-5422, 2006
Cited by (1)
-
38
- Endocytosis of adenovirus and adenovirus capsid proteins
-
MEDINA-KAUWE LK.
Adv Drug Deliv Rev 55, 1485-1496, 2003
Cited by (1)
-
39
- Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake
-
EGAMI T
Clin Cancer Res 14, 1859-1867, 2008
Cited by (1)
-
40
- Adenoviral infection of survivin antisense sensitizes prostate cancer cells to etoposide in vivo
-
HAYASHI N
Prostate 65, 10-19, 2005
Cited by (1)
-
41
- Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine
-
LEE WP
Cancer Res 63, 6229-6236, 2003
Cited by (1)
-
42
- Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand
-
REDDY RM
J Thorac Cardiovasc Surg 128, 883-891, 2004
Cited by (1)
-
43
- A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma
-
HECHT JR
Clin Cancer Res 9, 555-561, 2003
Cited by (1)
-
44
- Comparison for blood levels and clinical effects between tablet and other dossge forms of 5-fluorouracil
-
KIKUCHI K
Gan Kagaku Ryoho 6, 559-565, 1979
Cited by (1)
-
45
- Pharmacokinetics of cisplatin
-
SAWADA M
Sanfujinka No Jissai 32, 2117-2122, 1983
Cited by (1)
-
46
- Clinical trial of NK 171s (etoposide miniaturized hard capsule) on malignant lymphoma
-
PARK K.
Kiso Rinshou 26, 1136-1141, 1992
Cited by (1)
-
47
- Colorectal cancer : genetics of development and metastasis
-
TAKAYAMA TETSUJI , MIYANISHI KOJI , HAYASHI TSUYOSHI , SATO YASUSHI , NIITSU YOSHIRO
J Gastroenterol 41(3), 185-192, 2006-03-01
Ichushi Web References (98) Cited by (6)
-
48
- Adenoviral vectors : a promising tool for gene therapy
-
GHOSH SS
Appl Biochem Biotechnol 133, 9-29, 2006
Cited by (3)
-
49
- Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer
-
DIRENZO M. F.
Cancer Res 55, 1129-1138, 1995
Cited by (12)
-
50
- The role of epigenetic alterations in pancreatic cancer
-
SATO NORIHIRO , GOGGINS MICHAEL
J Hepatobiliary Pancreat Surg 13(4), 286-295, 2006-07-01
Ichushi Web References (113) Cited by (3)
-
51
- Molecular cloning and expression of human hepatocyte growth factor
-
NAKAMURA T.
Nature 342, 440-443, 1989
Cited by (166)
-
52
- Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocyte
-
SEKI T.
Biochem Biophys Res Commun 172, 321-327, 1990
Cited by (12)
-
53
- A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5
-
MCGRORY W. J.
Virology 163, 614-617, 1988
DOI Cited by (11)
-
54
- HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor
-
DATE K
FEBS Lett 420, 1-6, 1997
Cited by (13)
-
55
- Inhibition of tumor growth and invasion by a fourkringle antagonist (HGF/NK 4) for hepatocyte growth factor
-
DATE K
Oncogene 17, 3045-3054, 1998
DOI Cited by (12)
-
56
- Ultrastructural and immunofluorescence studies of early events in adenovirus-HeLa cell interactions
-
PATTERSON S.
J General Virol 64, 1091-1099, 1983
Cited by (3)
-
57
- Infectious entry pathway of adenovirus type 2
-
VARGA MJ
J Virol 65, 6061-6070, 1991
Cited by (1)
-
58
- Tubular membrane invaginations coated by dynamin rings are induced by GTP-gamma S in nerve terminals
-
TAKEI K.
Nature 374, 186-190, 1995
Cited by (16)
Cited by: 1
-
1
- Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells : tumor-tropic potential and inhibition of ovarian cancer cell growth
-
KIM Ki-Yon , KIM Seung U. , LEUNG Peter C. K. , JEUNG Eui-Bae , CHOI Kyung-Chul
Cancer science 101(4), 955-962, 2010-04-10
Ichushi Web References (53)